DIA Biosimilars 2013

University of Massachusetts

UMass, U.K. to collaborate on stem cell projects

Wednesday, March 23, 2011 12:11 PM

A collaboration surrounding stem cell categorization, distribution and possible funding for joint research projects has been signed between the University of Massachusetts Human Stem Cell Bank and Registry and the United Kingdom Stem Cell Bank, according to a report in Mass High Tech.

The signing took place in Hertfordshire, England during Massachusetts Governor Deval Patrick’s Innovation Economy Partnership Mission 2011, which has been touring Israel and Europe to drum up collaborations between researchers and companies in those areas and Massachusetts, primarily in the life sciences.

The two stem cell banks plan to share best practices for stem cell banking and to collaborate on standards for stem cell line characterization, production and distribution in the U.S. and the U.K.

The UMass Human Stem Cell Bank and Registry was proposed in 2007 and established in 2008, with funding from the $1 billion Life Sciences Act.  The registry started officially offering its seven stem cell lines to researchers working on treatments for cancer, Alzheimer’s disease, Parkinson’s disease and juvenile diabetes in 2011.

More... »

Cenduit: Now with Patient Reminders
CRF Health – eCOA Forum
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.